Ambar Protein Industries Ltd
Ambar Protein Industries Ltd (AMBARPIL) last reported results for the quarter ended Jun 2026, with sales of ₹113 crore and net profit of ₹3.75 crore. The stock last traded at ₹184, a market capitalisation of ₹106 crore, on a P/E of 10.6. Over the past 52 weeks the stock has ranged between ₹140 and ₹328. Figures are as of 9 Oct 2026 and are not real time.
Ambar Protein Industries Ltd share price and key metrics
- Current price
- ₹184
- Market cap
- ₹106 cr
- Stock P/E
- 10.6
- Book value
- ₹72.6
- ROE
- 18.4%
- ROCE
- 17.8%
- Dividend yield
- 0.00%
- 52w high / low
- 328/140
Metrics as of 9 Oct 2026. Not real time.
Track Ambar Protein Industries Ltd
Cruxal reads every Ambar Protein Industries Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Ambar Protein Industries Ltd growth and returns
- 10 Years
- 12%
- 5 Years
- 10%
- 3 Years
- 13%
- TTM
- 11%
- 10 Years
- 23%
- 5 Years
- 13%
- 3 Years
- 36%
- TTM
- 15%
- 10 Years
- %
- 5 Years
- 68%
- 3 Years
- -3%
- 1 Year
- -39%
- 10 Years
- 22%
- 5 Years
- 21%
- 3 Years
- 22%
- Last Year
- 18%
Ambar Protein Industries Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹113 cr, down 3.3% from ₹117 cr a year earlier. Net profit was ₹3.75 cr, up 400.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 88.95 | 112 | 128 | 117 | 112 | 125 | 147 | 113 |
| Expenses | 84.72 | 107 | 124 | 115 | 109 | 122 | 143 | 108 |
| Operating profit | 4.23 | 4.82 | 3.79 | 2.14 | 2.51 | 3.24 | 4.12 | 5.75 |
| OPM % | 4.76% | 4.31% | 2.97% | 1.82% | 2.25% | 2.59% | 2.81% | 5.07% |
| Other income | 0.22 | 0.19 | 0.2 | 0.19 | 0.18 | 0.19 | 0.22 | 0.19 |
| Interest | 0.56 | 0.57 | 0.58 | 0.53 | 0.45 | 0.5 | 0.55 | 0.47 |
| Depreciation | 0.32 | 0.46 | 0.21 | 0.33 | 0.34 | 0.34 | 0.36 | 0.36 |
| Profit before tax | 3.57 | 3.98 | 3.2 | 1.47 | 1.9 | 2.59 | 3.43 | 5.11 |
| Tax % | 24.65% | 29.15% | 22.19% | 48.98% | -5.26% | 29.73% | 27.99% | 26.61% |
| Net profit | 2.69 | 2.82 | 2.48 | 0.75 | 2 | 1.81 | 2.46 | 3.75 |
| EPS (₹) | 4.68 | 4.90 | 4.31 | 1.30 | 3.48 | 3.15 | 4.28 | 6.52 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Ambar Protein Industries Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 195 | 206 | 231 | 284 | 313 | 340 | 345 | 336 | 421 | 501 | 497 |
| Operating profit | 3 | 3 | 4 | 6 | 8 | 9 | 7 | 7 | 16 | 12 | 16 |
| OPM % | 1.3% | 1.5% | 1.7% | 2.1% | 2.5% | 2.8% | 2.1% | 2.2% | 3.7% | 2.4% | 3.1% |
| Net profit | 2 | 2 | 2 | 1 | 3 | 4 | 3 | 3 | 10 | 7 | 10 |
| EPS (₹) | 4.19 | 3.74 | 3.53 | 2.17 | 6.00 | 7.74 | 4.89 | 5.48 | 16.78 | 12.23 | 17.43 |
TTM is the trailing twelve months to the most recent quarter.
Ambar Protein Industries Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 0 | 2 | 4 | 5 | 9 | 13 | 16 | 19 | 29 | 36 |
| Borrowings | 10 | 18 | 24 | 27 | 27 | 33 | 29 | 26 | 26 | 26 |
| Other liabilities | 7 | 5 | 19 | 11 | 8 | 12 | 11 | 11 | 10 | 14 |
| Total liabilities | 23 | 31 | 53 | 49 | 50 | 64 | 62 | 61 | 71 | 82 |
| Fixed assets | 6 | 6 | 7 | 22 | 21 | 21 | 20 | 19 | 18 | 18 |
| CWIP | 0 | 6 | 16 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other assets | 17 | 19 | 31 | 27 | 29 | 44 | 42 | 42 | 51 | 63 |
| Total assets | 23 | 31 | 53 | 49 | 50 | 64 | 62 | 61 | 71 | 82 |
As reported by the company. Total assets equal total liabilities by construction.
Ambar Protein Industries Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -3 | 1 | 1 | 3 | 1 | -3 | 6 | 7 | 2 | 3 |
| Cash from investing | 0 | -5 | -10 | -1 | -0 | -0 | 0 | -0 | -0 | -1 |
| Cash from financing | 3 | 6 | 7 | -0 | -2 | 2 | -6 | -7 | -2 | -2 |
| Net cash flow | 1 | 1 | -2 | 1 | -1 | -0 | 0 | -0 | 0 | 0 |
| Free cash flow | -3 | -5 | -9 | 2 | 0 | -3 | 5 | 6 | 1 | 1 |
| CFO / operating profit | -100% | 51% | 45% | 59% | 23% | -17% | 108% | 103% | 30% | 56% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Ambar Protein Industries Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 22% | 17% | 13% | 15% | 18% | 19% | 13% | 13% | 28% | 18% |
| Debtor days | 8 | 3 | 2 | 3 | 4 | 10 | 15 | 15 | 18 | 7 |
| Inventory days | 19 | 16 | 37 | 20 | 22 | 32 | 23 | 24 | 20 | 30 |
| Days payable | 9 | 6 | 10 | 3 | 5 | 9 | 7 | 8 | 3 | 7 |
| Cash conversion cycle | 18 | 13 | 29 | 19 | 21 | 33 | 30 | 31 | 34 | 31 |
| Working capital days | -1 | -4 | -9 | -8 | -2 | 3 | 4 | 6 | 12 | 15 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Ambar Protein Industries Ltd shareholding pattern
Promoters held 73.87% at Sep 2026, up from 71.48% at Sep 2025.
| % held | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 71.35% | 71.35% | 71.35% | 71.48% | 72.07% | 72.69% | 73.76% | 73.87% |
| Public | 28.65% | 28.64% | 28.64% | 28.51% | 27.93% | 27.31% | 26.25% | 26.13% |
| No. of shareholders | 2,986 | 2,958 | 2,877 | 3,177 | 3,068 | 3,051 | 3,031 | 2,971 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Ambar Protein Industries Ltd corporate filings
- Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Company Updatelow impact
- Ambar Protein Industries Limited's 33rd AGM results indicate strong shareholder approval for key resolutions, with 100% voting in favor on all items including financial statements, director reappointments, remuneration, and related party transactions.AGM/EGMmedium impact
Cruxal's analysis: Ambar Protein Industries Limited reported full approval of all resolutions at its AGM…
Read the full analysis - Ambar Protein Industries Limited holds 33rd AGM; no immediate financial disclosures or strategic announcements evident from the documentAGM/EGMlow impact
Cruxal's analysis: The AGM proceedings for Ambar Protein Industries Limited, held on 30th September 2026…
Read the full analysis - Intimation- Closure of Trading WindowInsider Trading / SASTlow impact
- Ambar Protein Industries Ltd publishes newspaper notice regarding SEBI complianceCompany Updatelow impact
Cruxal's analysis: Ambar Protein Industries Ltd has issued a newspaper publication in accordance with SEBI…
Read the full analysis - Ambar Protein Industries Limited Announces 33rd Annual General Meeting for September 30, 2026Company Updatelow impact
Cruxal's analysis: Ambar Protein Industries Limited has issued a formal notice regarding its 33rd Annual…
Read the full analysis - Ambar Protein Industries Ltd confirms dispatch of Annual Report for FY 2025-2026Company Updatelow impact
Cruxal's analysis: Ambar Protein Industries Ltd has confirmed compliance with SEBI Regulation 36(1)(B) by…
Read the full analysis - Ambar Protein Industries Ltd schedules 33rd Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Ambar Protein Industries Ltd has submitted the formal notice for its 33rd Annual General…
Read the full analysis - Ambar Protein Industries Ltd. Announces Book Closure Dates for Annual General Meeting (AGM)Company Updatelow impact
Cruxal's analysis: Ambar Protein Industries Ltd. has formally notified the Bombay Stock Exchange regarding…
Read the full analysis - Ambar Protein Industries Ltd submits FY 2025-26 Annual Report and schedules 33rd AGM for September 30, 2026Otherslow impact
Cruxal's analysis: Ambar Protein Industries has filed its Annual Report for the financial year 2025-26 in…
Read the full analysis - Ambar Protein Industries Ltd. Reports Audited Standalone Financial Results for Quarter Ended June 30, 2026Company Updatehigh impact
Cruxal's analysis: Ambar Protein Industries Ltd. has released its audited standalone financial results for…
Read the full analysis - Ambar Protein Industries Q1 FY27 PAT surges 402% YoY to 3.75 crore on improved operational efficiencyBoard Meetinghigh impact
Cruxal's analysis: Ambar Protein Industries reported strong Q1 FY27 results with a net profit of 3.75 crore…
Read the full analysis - Ambar Protein Industries Limited schedules Board Meeting for August 14, 2026, to approve Q1 FY27 financial results and management remunerationBoard Meetinglow impact
Cruxal's analysis: Ambar Protein Industries Limited has announced a board meeting scheduled for August 14…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.